Insights to Cure Disease and Heal Healthcare

Understand the power of causal machine learning and why it’s different than other AI solutions for driving precision medicine and discovering what works for whom.

Learn More

The Best Science is Peer Reviewed

Check out our growing library of journal articles, posters, abstracts, and presentations to learn how our results are changing biomedicine and healthcare.

Learn More

There’s a Lot of Noise Around AI

Download our infographic to learn about the types of AI and what you need to consider when choosing the right solution and the right partner.

Learn More

GNS Healthcare applies its groundbreaking, powerful artificial intelligence (AI) platform to unravel the complexity of human disease in order to match the right treatment to the right patient at the right time.

We work with leading biopharma companies to accelerate and optimize drug discovery, development and commercialization. Our platform leverages both clinical trial data and real world data (RWD) to model patient response to treatment in silico. These insights enable biopharma to discover which subpopulations of patients respond, which do not and more importantly understand why, directly from the data and without bias. These models can also be used to conduct in silico clinical trials generating real world evidence of a drug’s value in the real world, both before and after launch.

We partner with innovative health plans to identify which members will respond to which drug and care management interventions at what point in time. Our platform provides a prescriptive approach allowing health plans to understand the effectiveness of specific interventions, member by member.

We work with progressive patient foundations to discover novel disease pathways and drug targets to accelerate the development of new therapeutics.

By leveraging the most powerful form of AI, called causal machine learning, we transform massive and diverse data streams to precisely match therapeutics, procedures, and care management interventions to individuals to dramatically improve health outcomes and reduce the total cost of care. We have modeled over forty diseases in the areas of oncology, cardiovascular and metabolic, neurology, autoimmune and others.

We understand that in order to make precision medicine a reality, we need to discover and deliver novel insights that will cure disease and heal the healthcare system.

OUR AI PLATFORM: REFS™

REFS (Reverse Engineering Forward Simulation) uncovers the cause and effect relationships from data at scale to solve healthcare’s matching problem and make precision medicine a reality.

Speed to discovery

Our platform works by reconstructing complex diseases into computer models which allows users to simulate real world scenarios that take the guesswork out of critical decisions and increase the speed to discovery from years to months.

Transparency of results

By employing causal machine learning, our models not only deliver novel insights, they identify the underlying cause and effect relationships, crucial to understanding and treating the root cause of disease progression and patient response.

Unlimited data volume and variety

We transform and integrate millions of data points of all types – EMR, genetic, proteomic, genomic, claims, consumer, laboratory, prescription, mobile health, sociodemographic and more – revealing unforeseen relationships in a dynamic platform that continues to grow smarter over time.
 

Healthcare’s Most Powerful AI Solution

Understand the power of causal machine learning, why it’s different than other AI solutions and why it’s critical to transform biomedicine and healthcare. Check out video below to learn more.

GNS By The Numbers

We’re all about data points, numbers and evidence.

Complex Models Built

Data Points Modeled

Years Applying AI to Healthcare

Diseases Modeled

Peer Reviewed Journal Articles & Posters

Our Clients

{"infinite":"true","pause_on_hover":"false","adaptive_height":"false","items":"5","auto_play":"true","speed":"1000","rtl_mode":"false","dots":"false","nav":"false","slides_to_scroll":"1","slides_to_scroll_mobile":"1","auto_play_speed":"1000","draggable":"true","swipe":"true","lazy":"false","carousel_mode":"standard","center_mode":"false","center_mode_padding":"60px","vertical":"false","nav_type":"nav_arrow","items_desktop":"4","items_desktop_small":"3","items_tablet":"2","items_mobile":"1","nav_arrow_type_horizon":"angle_arrow_horizon"}
National Cancer Institute
National Institute of Health
Johnson and Johnson
Novartis
Covance
Cambia
Celgene
CMS
GGG
Inova
Horizon
MJF
MMRF
Icahn
Orion
RetroFit
UC SanDiego
UCSF
Alliance
Bristol Meyers
ALS
Answer ALS
Swedish Cancer Institute
Janssen
Sema4

Our Blog

Read More Blog Posts >>

News & Events

Featured Content

Improving The Probability of Success: New Tools in Drug Development

How robust data and powerful AI is changing the way drugs are developed.

Download

Why BioPharma Needs AI to Succeed

Check out our infographic to see why biopharma needs AI to succeed.

Download